We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Photodynamic Therapy, Luminol Used to Kill Cancer cells

By Biotechdaily staff writers
Posted on 02 Aug 2006
Forcing cancer cells to light up could activate light-sensitive drugs that are then able to kill them without damaging nearby healthy tissue, according to recent research.

Researchers based at the College of Judea and Samaria (Ariel) and in association with Bar-Ilan University (Ramat Gan), both in Israel, have for the first time combined two novel techniques to target cancer cells. More...
The first is a form of photodynamic therapy, which delivers a light-sensitive drug specifically to cancer cells. The second technique uses a compound called luminol to generate light inside individual cells, activating the drug and killing the cell. The scientists reported their findings in the July 18, 2006, edition of the British Journal of Cancer.

Photodynamic therapy exploits the properties of specific chemicals that are triggered by normal visible light. In photodynamic therapy, laser light is shone from outside the body to activate chemotherapy drugs. Now it may be possible to use luminol to produce light inside cells, reducing side effects, and enabling the therapy to be used to treat a wider range of tumors.

Lead researcher Dr. Michael Firer, of the department of chemical engineering and Biotechnology at the College of Judea and Samaria, said, "The two big problems with photodynamic therapy are getting the light-sensitive drug to only target cancer cells, and delivering light to the drug to activate it once it is in the right place. We've uniquely combined two cutting-edge technologies to direct a drug to cancer cells and to generate a light source inside the cells. This stops the drug from killing healthy cells. It also means that we might be able to use photodynamic therapy to treat tumors deep inside the body that external light sources cannot reach. We've shown it works in the lab--if it works in real life, we'll have an exciting new way to treat cancer.”

Another unexpected and positive result of using targeted photodynamic therapy was that it removed the drug resistance that develops when untargeted therapies are employed.

Prof. John Toy, medical director of Cancer Research UK, which owns the British Journal of Cancer, remarked, "These are promising results, although there is a long way to go before we can know if this will work in patients. If it does work, it could become a safe, non-invasive option for treating many types of cancers.”



Related Links:
College of Judea and Samaria
Bar-Ilan University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Platelet Function Analyzer
PL-12
Automatic CLIA Analyzer
Shine i6000
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

New Insights Into Fetal DNA Could Improve Non-Invasive Prenatal Testing

Non-invasive prenatal testing is widely used to screen pregnancies for genetic conditions by analyzing DNA fragments in maternal blood. Although it offers a safer alternative to invasive procedures such... Read more

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.